NASDAQ · Biotechnology

GDTC (GDTC) Stock

$0.93 -5.99% NASDAQ: GDTC Healthcare

Valuation

MetricValue
Price$0.93
Market Cap$11.01M
P/E Ratio-4.00
P/B Ratio2.23
P/S Ratio36.66
EPS (TTM)$-0.33
52-Week High$3.68
52-Week Low$0.68
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.14%
ROA-50.00%
ROCE-71.43%
Gross Margin-63.95%
Operating Margin-10.75%
Net Margin-10.62%
Debt/Equity0.07
Current Ratio4.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-2.0M$-3.0M$-3.0M$-5.0M
Net Profit$-2.0M$-2.0M$-3.0M$-2.0M$-4.0M
EPS$-0.22$-0.30$-0.29$-0.16$-0.33
Op Margin-1661.4%—-1101.0%-5049.8%-1416.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.0M$4.0M$9.0M$7.0M$8.0M
Total Liabilities$3.0M$3.0M$1.0M$1.0M$1.0M
Cash$2.0M$1.0M$7.0M$4.0M$2.0M
Borrowings$2.0M$3.0M$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-3.0M$-2.0M$-4.0M
Investing Cash Flow$-1.0M$-1.0M$-2.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$-1.0M$4.0M$-1.0M$-3.0M
Free Cash Flow$-2.0M$-1.0M$-3.0M$-3.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-33.59%
Quick Ratio5.17
Interest Coverage—
Return 1Y-50.00%
Return 3Y-76.50%
Return 5Y—

Ownership

Insiders Held68.78%
Institutions Held0.18%
Institutions Float Held0.57%
Institutional HolderSharesReport Date
Xtx Topco Ltd10,1362026-03-31
UBS Group AG6,1822026-03-31
Osaic Holdings Inc.212026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About GDTC

GDTC is led by CEO Chee Kong Choo, employs 43 people, headquartered in SG, publicly traded since 2023.

GDTC stock trades at $0.93 with a market capitalization of $11.01M. The stock is valued at a price-to-earnings (P/E) ratio of -4.00, price-to-book of 2.23, price-to-sales of 36.66. Over the past 52 weeks the stock has ranged between $0.68 and $3.68, and currently trades 74.7% below its 52-week high.

On profitability, GDTC generates a return on equity (ROE) of -57.14%, return on capital employed of -71.43%, an operating margin of -10.75%, a net profit margin of -10.62%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides